한국인 신경병성 동통 환자의 치료 양태 연구 = Treatment Pattern of Patients with Neuropathic Pain in Korea

다국어 초록 (Multilingual Abstract)

The purpose of this study was to investigate the treatment pattern of patients with neuropathic pain (NeP) in Korea through computerized database of Health Insurance Review and Assessment Service (HIRAS) over three years' period from 2003 to 2005. The results showed that the numbers of treatment visits were the highest for diabetic neuropathy (DN), followed by postherpetic neuralgia (PHN) and trigeminal neuralgia (TN) in order. Top 3 specialties for treatment visits due to NeP conditions were neurology, neurosurgery and anesthesiology. While cost of a treatment visit was higher in anesthesiology and emergency clinics compared to other clinics, there was a tendency to increase costs for visits to clinics of rehabilitation medicine and family medicine over the three years. Cost of dental visits was relatively high for TN, atypical facial pain (AFP) and atypical odontalgia (AO). Surgeries frequently applied to patients with NeP were sympathetic plexus or ganglion block, block of peripheral branch of spinal nerve and cranial nerve or its peripheral branch block. Most common prescribed medication were anticonvulsants, anti-inflammatory analgesics and anti-psychotic drugs while anti-inflammatory analgesics were overwhelmingly frequently prescribed for AO and glossodynia. Based on the results of this study, NeP disorders more relevant to dentists were AO, TN and AFP, TN of which seems to be the most important in terms of patients' number and cost for treatment visits. This indicates that dentists, especially oral medicine specialists should actively participate in management of TN, AO and AFP and share relevant information with patients and community.

참고문헌 (Reference)

1 원정연, "한국의 신경병성 동통 환자에 대한 역학조사" 대한안면통증∙구강내과학회 33 (33): 353-374, 2008

2 한국 표준질병-사인분류, "통계청: 대한 의무기록협회 제3권" 2003

3 Torrance N, "The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population study" 7 : 281-289, 2006

4 Johnson MI, "Tanscutaneous electrical nerve stimulation (TENS) and acupuncure, In: Neuropathic pain" Oxford University Press 117-124, 2006

5 Moulin DE, "Pharmacological management of chronic neuropathic pain-Consensus statement and guidelines from the Canadian Pain Society" 12 : 13-21, 2007

6 Dworkin RH, "Pharmacologic management of neuropathic pain: Evidence-based recommendations" 132 : 237-251, 2007

7 Bennet G, "Neuropathic pain: An overview. In: Molecular neurobiology of pain" IASP Press 109-113, 1997

8 Simpson KH, "Intrathecal drug delivery and neurolytic blocks, In: Neuropathic pain" Oxford University Press 141-144, 2006

9 Hall GC, "Epidemiology and treatment of neuropathic pain: The UK primary care perspective" 122 : 156-162, 2006

10 Smith BH, "Epidemiolgy, In: Neuropathic pain" Oxford University Press 19-, 2006

11 Attal N, "EFNS guideline on pharmacological treatment of neuropathic pain" 13 : 1153-1169, 2006

12 Burger A, "Clinical characteristics and economic costs of patients with painful neuropathic disorders" 5 : 143-149, 2004

13 Merskey H, "Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed." IASP Press 212-, 1994

14 McQuay HJ, "Antidepressants and anti-epileptics for neuropathic pain, In: Neuropathic pain" Oxford University Press 79-87, 2006

15 Dworkin RH, "An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms" 18 : 343-349, 2002